Search results
Explainer-What are the FLiRT COVID variants and are they more contagious?
KFGO· 15 hours agoBy Michael Erman NEW YORK (Reuters) - The so-called FLiRT variants of SARS-CoV-2 coronavirus that...
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 3 days agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 10 hours agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 13 hours agoBut that was largely due to flagging sales of its COVID-19 vaccine and Paxlovid treatment for...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 2 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of ...
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 3 days agoImage source: Getty Images. 1. Novavax's new partnership may supercharge its revenue growth, but don't expect pandemic-level sales Novavax's vaccine...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 2 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID-19 pandemic in the ...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 2 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 9 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 6 days agoBut what if it succeeds? Moderna, Pfizer, and now Sanofi are developing competing combination ...